Medical Innovation Acceleration Act of 2025
January 3, 2025
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
Where This Stands
Currently in_committee. The next step in the legislative lifecycle is Floor Vote.
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →The Frame
The bill establishes a framework for federal oversight of medical research and development, which could change the timeline and requirements for bringing new medical products to the public market.
Potentially affected actors named in the source documents. Mention is not a position.
House Committee on Energy and Commerce
The committee is responsible for reviewing, debating, and deciding whether to advance the bill to the House floor.
Medical research and pharmaceutical industries
These entities are subject to the regulatory changes and approval processes proposed in the legislation.
Current stage: in_committee.
Floor Vote.
Summary
Key Facts
- The bill is designated as HR.
- The bill has been formally referred to the House Committee on Energy and Commerce for review.
Frequently Asked Questions
What is the current status of this bill?
What is the goal of the Medical Innovation Acceleration Act?
Why It Matters
The bill establishes a framework for federal oversight of medical research and development, which could change the timeline and requirements for bringing new medical products to the public market.
News Coverage
Sponsors
Connected Entities
Analysis Score
0–100- Significance40How much this matters to a regular citizen
- Controversy10Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz15Current news / social attention level
Publisher tools